Effect of Metoclopramide on Gastric Volume and Nausea and Vomiting in Fasted Patients Undergoing Elective Cesarean Delivery: A Randomized Clinical Equivalence Trial
( Int J Obstet Anesth . 2025;64:104754. doi:10.1016/j.ijoa.2025.104754) Current obstetric anesthesia guidelines recommend preoperative fasting and aspiration prophylaxis, including metoclopramide, despite limited contemporary evidence supporting its benefit in low-risk, fasted parturients. Given the medication’s known side-effect profile, its routine use in this population warrants further examination. In this study, the authors conducted a randomized, double-blind, placebo-controlled equivalence trial that evaluated whether intravenous (IV) metoclopramide meaningfully reduces gastric volume or improves nausea and vomiting outcomes in appropriately fasted patients undergoing elective cesarean delivery (CD).
Authors
- PE Ripchik
- MB Troughton
- RJ McCarthy
- AG Samworth
- CL Thomas
- SF Lu
- JH Kruse
- P Toledo
- CE Lopez
- JM Banayan
- IN Gaston
Publication Details
- Journal
- Obstetric Anesthesia Digest
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1097/01.aoa.0001288944.21906.a7
- Primary Topic
- Nausea and vomiting management
- Type
- article
- Field-Weighted Citation Impact
- 0.00